Matches in Nanopublications for { ?s ?p "[The prevalence and uniformity of FSIP1 expression in breast tumors, taken together with the highly restricted expression in normal tissues, suggests that FSIP1 may be an attractive target for breast cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP977334.RACf3CYRuxgFPa9Dj-BUGMq_KqDijskD0efJlljaW-IKI130_assertion description "[The prevalence and uniformity of FSIP1 expression in breast tumors, taken together with the highly restricted expression in normal tissues, suggests that FSIP1 may be an attractive target for breast cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977334.RACf3CYRuxgFPa9Dj-BUGMq_KqDijskD0efJlljaW-IKI130_provenance.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion description "[The prevalence and uniformity of FSIP1 expression in breast tumors, taken together with the highly restricted expression in normal tissues, suggests that FSIP1 may be an attractive target for breast cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- NP1098640.RAM9mQio0yY73_jxmj2lPLJhQ7vg9ubn_4QvkS3Er4UWE130_assertion description "[The prevalence and uniformity of FSIP1 expression in breast tumors, taken together with the highly restricted expression in normal tissues, suggests that FSIP1 may be an attractive target for breast cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1098640.RAM9mQio0yY73_jxmj2lPLJhQ7vg9ubn_4QvkS3Er4UWE130_provenance.
- NP977339.RAKu6zRFAnWerrVTIwbXvNNZu_QuVzjvYmX9Jnt53Hj-8130_assertion description "[The prevalence and uniformity of FSIP1 expression in breast tumors, taken together with the highly restricted expression in normal tissues, suggests that FSIP1 may be an attractive target for breast cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977339.RAKu6zRFAnWerrVTIwbXvNNZu_QuVzjvYmX9Jnt53Hj-8130_provenance.